Advertisement

Index by author

May 01, 2022; Volume 101,Issue 5

  1. Dogra, Shalini

    1. Metabotropic Glutamate Receptors As Emerging Targets for the Treatment of Schizophrenia
      Shalini Dogra and P. Jeffrey Conn
      Molecular Pharmacology May 2022, 101 (5) 275-285; DOI: https://doi.org/10.1124/molpharm.121.000460

  2. Farrant, Mark

    1. Open Access
      Influence of the TARP γ8-Selective Negative Allosteric Modulator JNJ-55511118 on AMPA Receptor Gating and Channel Conductance
      Ian D. Coombs, Craig A. Sexton, Stuart G. Cull-Candy and Mark Farrant
      Molecular Pharmacology May 2022, 101 (5) 343-356; DOI: https://doi.org/10.1124/molpharm.121.000473

  3. Fujita, Jun

    1. Nuclear Ceramide Is Associated with Ataxia Telangiectasia Mutated Activation in the Neocarzinostatin-Induced Apoptosis of Lymphoblastoid Cells
      Nuclear Ceramide Is Associated with Ataxia Telangiectasia Mutated Activation in the Neocarzinostatin-Induced Apoptosis of Lymphoblastoid Cells
      Jun Fujita, Makoto Taniguchi, Chieko Hashizume, Yoshibumi Ueda, Shota Sakai, Tadakazu Kondo, Mayumi Hashimoto-Nishimura, Kentaro Hanada, Takeo Kosaka and Toshiro Okazaki
      Molecular Pharmacology May 2022, 101 (5) 322-333; DOI: https://doi.org/10.1124/molpharm.121.000379

  4. Goldspink, Paul H.

    1. Effects of Sarcomere Activators and Inhibitors Targeting Myosin Cross-Bridges on Ca<sup>2+</sup>-Activation of Mature and Immature Mouse Cardiac Myofilaments
      Effects of Sarcomere Activators and Inhibitors Targeting Myosin Cross-Bridges on Ca2+-Activation of Mature and Immature Mouse Cardiac Myofilaments
      Monika Halas, Paulina Langa, Chad M. Warren, Paul H. Goldspink, Beata M. Wolska and R. John Solaro
      Molecular Pharmacology May 2022, 101 (5) 286-299; DOI: https://doi.org/10.1124/molpharm.121.000420

  5. Gresham, Robert

    1. VU6036720: The First Potent and Selective In Vitro Inhibitor of Heteromeric Kir4.1/5.1 Inward Rectifier Potassium Channels
      Samantha J. McClenahan, Caitlin N. Kent, Sujay V. Kharade, Elena Isaeva, Jade C. Williams, Changho Han, Andrew Terker, Robert Gresham, Roman M. Lazarenko, Emily L. Days, Ian M. Romaine, Joshua A. Bauer, Olivier Boutaud, Gary A. Sulikowski, Raymond Harris, C. David Weaver, Alexander Staruschenko, Craig W. Lindsley and Jerod S. Denton
      Molecular Pharmacology May 2022, 101 (5) 357-370; DOI: https://doi.org/10.1124/molpharm.121.000464

  6. Halas, Monika

    1. Effects of Sarcomere Activators and Inhibitors Targeting Myosin Cross-Bridges on Ca<sup>2+</sup>-Activation of Mature and Immature Mouse Cardiac Myofilaments
      Effects of Sarcomere Activators and Inhibitors Targeting Myosin Cross-Bridges on Ca2+-Activation of Mature and Immature Mouse Cardiac Myofilaments
      Monika Halas, Paulina Langa, Chad M. Warren, Paul H. Goldspink, Beata M. Wolska and R. John Solaro
      Molecular Pharmacology May 2022, 101 (5) 286-299; DOI: https://doi.org/10.1124/molpharm.121.000420

  7. Han, Changho

    1. VU6036720: The First Potent and Selective In Vitro Inhibitor of Heteromeric Kir4.1/5.1 Inward Rectifier Potassium Channels
      Samantha J. McClenahan, Caitlin N. Kent, Sujay V. Kharade, Elena Isaeva, Jade C. Williams, Changho Han, Andrew Terker, Robert Gresham, Roman M. Lazarenko, Emily L. Days, Ian M. Romaine, Joshua A. Bauer, Olivier Boutaud, Gary A. Sulikowski, Raymond Harris, C. David Weaver, Alexander Staruschenko, Craig W. Lindsley and Jerod S. Denton
      Molecular Pharmacology May 2022, 101 (5) 357-370; DOI: https://doi.org/10.1124/molpharm.121.000464

  8. Hanada, Kentaro

    1. Nuclear Ceramide Is Associated with Ataxia Telangiectasia Mutated Activation in the Neocarzinostatin-Induced Apoptosis of Lymphoblastoid Cells
      Nuclear Ceramide Is Associated with Ataxia Telangiectasia Mutated Activation in the Neocarzinostatin-Induced Apoptosis of Lymphoblastoid Cells
      Jun Fujita, Makoto Taniguchi, Chieko Hashizume, Yoshibumi Ueda, Shota Sakai, Tadakazu Kondo, Mayumi Hashimoto-Nishimura, Kentaro Hanada, Takeo Kosaka and Toshiro Okazaki
      Molecular Pharmacology May 2022, 101 (5) 322-333; DOI: https://doi.org/10.1124/molpharm.121.000379

  9. Harris, Raymond

    1. VU6036720: The First Potent and Selective In Vitro Inhibitor of Heteromeric Kir4.1/5.1 Inward Rectifier Potassium Channels
      Samantha J. McClenahan, Caitlin N. Kent, Sujay V. Kharade, Elena Isaeva, Jade C. Williams, Changho Han, Andrew Terker, Robert Gresham, Roman M. Lazarenko, Emily L. Days, Ian M. Romaine, Joshua A. Bauer, Olivier Boutaud, Gary A. Sulikowski, Raymond Harris, C. David Weaver, Alexander Staruschenko, Craig W. Lindsley and Jerod S. Denton
      Molecular Pharmacology May 2022, 101 (5) 357-370; DOI: https://doi.org/10.1124/molpharm.121.000464

  10. Hashimoto-nishimura, Mayumi

    1. Nuclear Ceramide Is Associated with Ataxia Telangiectasia Mutated Activation in the Neocarzinostatin-Induced Apoptosis of Lymphoblastoid Cells
      Nuclear Ceramide Is Associated with Ataxia Telangiectasia Mutated Activation in the Neocarzinostatin-Induced Apoptosis of Lymphoblastoid Cells
      Jun Fujita, Makoto Taniguchi, Chieko Hashizume, Yoshibumi Ueda, Shota Sakai, Tadakazu Kondo, Mayumi Hashimoto-Nishimura, Kentaro Hanada, Takeo Kosaka and Toshiro Okazaki
      Molecular Pharmacology May 2022, 101 (5) 322-333; DOI: https://doi.org/10.1124/molpharm.121.000379
« Previous (Pages : 1 2 3 4 5 6 ... 6) Next »
Back to top

In this issue

Advertisement